The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 29th 2025
At Asembia’s AXS25 Summit, Shea Hudson spotlighted how pharmacists are transforming into essential clinical partners through advanced technology, patient advocacy, and value-based collaboration.
Advocacy Group Seeks Personal Injury Lawyers for People Injured by Pharmacy Errors
March 5th 2019In a statement, the group said it conducted a half-year investigation into pharmacies dispensing prescriptions to the wrong people, and has found that a significant enough problem exists nationwide to warrant the action.
Read More
Health Systems Share Their Approaches to Improve Patient Engagement
March 5th 2019In one example cited in the paper, officials with Ochsner Health System reported using their online patient portal to help treat hypertension with a novel digital medicine program that combined patient-reported blood pressure data, clinical data, and coaching.
Read More
Walgreens Expands 'Feel More Like You' Program
March 5th 2019Feel More Like You was developed in collaboration with Look Good, Feel Better Foundation, the leading cancer support organization focusing attention on the appearance and beauty needs of cancer patients, and Cancer Support Community, the largest professionally led, nonprofit network of cancer support worldwide.
Read More
Report: Higher Health Care Spending Caused by Rising Prices, Not Utilization
March 5th 2019The 2017 Health Care Cost and Utilization Report examined medical and prescription drug spending, utilization, and average prices using health care claims data from 2013 through 2017 for Americans under the age of 65 who were covered by employer-sponsored insurance.
Read More
Study: 2 Strains of HPV Decrease Due to HPV Vaccination
March 3rd 2019Investigators from the CDC Human Papillomavirus (HPV) Vaccine Impact Monitoring Project (HPV-IMPACT) sought to determine whether HPV types 16 and 18, which are responsible for approximately 70% of cervical cancers worldwide, are also decreasing.
Read More
Analysis: Dupilumab Improves Quality of Life for Patients With Atopic Dermatitis
March 2nd 2019Analysis of care in a routine clinical practice setting show that 40-week treatment of biologic dupilumab (Dupixent, Sanofi-Regeneron) plus noncosmetic topical moisturizer (emollient) is associated with significantly improved symptoms and health-related quality of life (HRQoL) in particular patients with atopic dermatitis (AD).
Read More
FDA: New Nitrosamine Impurity Detected in Certain Losartan Lots
March 2nd 2019The recalled losartan potassium tablets made by Hetero Labs and distributed by Camber Pharmaceuticals contain the impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), which is a known animal and potential human carcinogen.
Read More
Subcutaneous Herceptin Combo Therapy for Certain Breast Cancer Patients Granted FDA Approval
February 28th 2019Trastuzumab and hyaluronidase-oysk (Herceptin Hylecta, Genentech) is indicated for subcutaneous administration in certain patients with HER2-positive early and metastatic breast cancer.
Read More